TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12028212

Group type: EXPERIMENTAL
Intervention: Mailed written materials
Number of subjects: 735

Group type: COMPARATOR
Intervention: Written materials plus a videotape
Number of subjects: 735
Study: 9608782

Group type: EXPERIMENTAL
Intervention: Group I (Mexico City)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Group II (Tula, Hidalgo)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Group III (Contepec, Michoacán)
Number of subjects: 71
Study: 7630245

Group type: EXPERIMENTAL
Intervention: Maximum androgen blockade (MAB) - castration plus prolonged use of an antiandrogen (flutamide, cyproterone acetate, or nilutamide)
Number of subjects: 5710

Group type: COMPARATOR
Intervention: Conventional castration (surgical or medical)
Number of subjects: 5710

Group type: EXPERIMENTAL
Intervention: Maximum androgen blockade (MAB)
Number of subjects: 5710

Group type: COMPARATOR
Intervention: Conventional castration
Number of subjects: 5710

Group type: EXPERIMENTAL
Intervention: Overall MAB trials
Number of subjects: 5710
Study: 2258895

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 30
Study: 6102454

Group type: EXPERIMENTAL
Intervention: Implantation of the internal mammary artery into the left ventricular myocardium
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 146
Study: 30348460

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg on day 0, 10 mg on day 1, 5 mg on day 2)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (standard treatment only)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control
Number of subjects: 76
Study: 28756278

Group type: EXPERIMENTAL
Intervention: Weight loss diet (D)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Weight loss diet plus exercise (D + E)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Exercise control group (E)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 429
Study: 26231498

Group type: EXPERIMENTAL
Intervention: Psilocybin (moderate dose)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 24494286

Group type: EXPERIMENTAL
Intervention: Electroacupuncture plus warm needling therapy (EA + WN)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Warm needling therapy (WN)
Number of subjects: 93
Study: 21482928

Group type: EXPERIMENTAL
Intervention: GRN+ FTLD-TDP
Number of subjects: 97

Group type: COMPARATOR
Intervention: GRN- FTLD-TDP
Number of subjects: 97
Study: 19399980

Group type: EXPERIMENTAL
Intervention: Daily interruption of sedative infusions
Number of subjects: 97

Group type: COMPARATOR
Intervention: Sedation as directed by the intensive care unit team (control)
Number of subjects: 97
Study: 17531920

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (nicotine content, 0.9 mg)
Number of subjects: 52
Study: 14745677

Group type: EXPERIMENTAL
Intervention: Heparin surface-modified PMMA intraocular lenses (HSM-IOLs)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Foldable hydrophobic acrylic intraocular lenses (Acrysof-IOLs)
Number of subjects: 18
Study: 11550111

Group type: EXPERIMENTAL
Intervention: temocapril
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: amlodipine
Number of subjects: 46

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 46
Study: 9491830

Group type: EXPERIMENTAL
Intervention: Volumatic spacer
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NebuChamber spacer
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sidestream nebuliser
Number of subjects: 12
Study: 7868850

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 3583070

Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 50
Study: 30334920

Group type: EXPERIMENTAL
Intervention: HIIT (12 weeks, cycle ergometer, progressive volume 6-12 series, intensity 140%-170% lactate threshold)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study: 28052885

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified young-child formula (YCF) (1.2 mg Fe/100 mL; 1.7 μg vitamin D/100 mL)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified young-child formula (YCF)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Nonfortified cow milk (CM) (0.02 mg Fe/100 mL; no vitamin D)
Number of subjects: 318
Study: 25439429

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept 2.0 mg every 8 weeks (2q8)
Number of subjects: 2419

Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg every 4 weeks (0.5q4)
Number of subjects: 2419
Study: 22360365

Group type: EXPERIMENTAL
Intervention: Multilink Sprint (Ivoclar Vivadent)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RelyX Unicem (3M ESPE, USA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: G-Cem (GC, Japan)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Variolink II (Ivoclar Vivadent)
Number of subjects: 40
Study: 20060790

Group type: EXPERIMENTAL
Intervention: 500 mg cefuroxime tablet
Number of subjects: 36
Study: 17106277

Group type: EXPERIMENTAL
Intervention: vCP1452 alone
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: vCP1452 plus rgp120
Number of subjects: 330

Group type: COMPARATOR
Intervention: vCP1452 alone and rgp120
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 15501926

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (acute: bolus 0.06; drip 0.02 g/kg fat-free mass)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (chronic: 500 mg/day for 30 days)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 22
Study: 11772423

Group type: EXPERIMENTAL
Intervention: Postmenopausal hormone replacement therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hormone replacement therapy
Number of subjects: 50
Study: 9788685

Group type: EXPERIMENTAL
Intervention: Cetirizine 5 mg with sustained-release pseudoephedrine (PSE) 120 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7658780

Group type: EXPERIMENTAL
Intervention: Controlled-release melatonin (2 mg per night for 3 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (for 3 weeks)
Number of subjects: 12
Study: 2501598

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (transdermal administration via Nitroderm TTS 10 for 48 hours)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 57507

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 350
Study: 31233972

Group type: EXPERIMENTAL
Intervention: National MMT training
Number of subjects: 418

Group type: COMPARATOR
Intervention: Stigmatizing attitudes towards PWUD
Number of subjects: 418
Study: 29444522

Group type: EXPERIMENTAL
Intervention: Antipsychotic medication alone
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Combined treatment (antipsychotic medication + psychosocial intervention)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 168
Study: 27502589

Group type: EXPERIMENTAL
Intervention: ACEMg (β-carotene, ascorbic acid, dl-α-tocopherol acetate, magnesium) administered twice daily for approximately 3 months
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: ACEMg treatment
Number of subjects: 140
Study: 25003274

Group type: EXPERIMENTAL
Intervention: CPAP (5 cmH2O) during exercise tests at 75% of peak work rate of incremental test (IT)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: CPAP (5 cmH2O) at rest and during exercise tests at 50% of peak work rate of IT
Number of subjects: 7
Study: 23479993

Group type: EXPERIMENTAL
Intervention: OCA7 (omeprazole 0.04 g/day, clarithromycin 1 g/day, amoxicillin 2 g/day for 7 days)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: OCA14 (same drugs for 14 days)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: OCA7L1 (same drugs for 7 days + glucosaminylmuramyldipeptide 0.001 g/day for 1 day)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: OCA7L10 (same drugs for 7 days + glucosaminylmuramyldipeptide 0.01 g/day for 10 days)
Number of subjects: 128

Group type: COMPARATOR
Intervention: OCA7 with glucosaminylmuramyldipeptide 0.001 g/day
Number of subjects: 128
Study: 20580870

Group type: EXPERIMENTAL
Intervention: teriparatide 20 microg/day
Number of subjects: 207

Group type: COMPARATOR
Intervention: placebo-teriparatide
Number of subjects: 207
Study: 17081536

Group type: EXPERIMENTAL
Intervention: Crinone 8% vaginal P gel (90 mg) administered daily
Number of subjects: 285

Group type: COMPARATOR
Intervention: Utrogestan vaginal capsules (2 x 100 mg) administered three times daily
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Crinone 8% vaginal P gel
Number of subjects: 285

Group type: COMPARATOR
Intervention: Utrogestan vaginal capsules
Number of subjects: 285
Study: 16128936

Group type: EXPERIMENTAL
Intervention: Esomeprazole (20 mg b.i.d.), clarithromycin (500 mg b.i.d.), and amoxicillin (1 g b.i.d.) for 7 days (E20-7d)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Esomeprazole (40 mg b.i.d.) with the same antibiotics for 7 days (E40-7d)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Esomeprazole (40 mg b.i.d.) with the same antibiotics for 10 days (E40-10d)
Number of subjects: 450
Study: 12113566

Group type: EXPERIMENTAL
Intervention: Healon 5
Number of subjects: 54

Group type: COMPARATOR
Intervention: Healon
Number of subjects: 54
Study: 10465924

Group type: EXPERIMENTAL
Intervention: 1 mg hydromorphone s.c.
Number of subjects: 60

Group type: COMPARATOR
Intervention: 50 mg meperidine i.m.
Number of subjects: 60
Study: 8576333

Group type: EXPERIMENTAL
Intervention: BacT/Alert Aerobic FAN bottle
Number of subjects: 483

Group type: COMPARATOR
Intervention: BACTEC Plus Aerobic/F bottle
Number of subjects: 483
Study: 2259918

Group type: EXPERIMENTAL
Intervention: NOAC I (high-dose cytarabine 3 g/m2/12 h on day 1 + mitoxantrone 10 mg/m2/d on days 2 and 3)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: NOAC II (high-dose cytarabine 3 g/m2/12 h on days 1 and 2 + mitoxantrone 10 mg/m2/d on days 2 and 3) with rhGM‐CSF
Number of subjects: 31

Group type: COMPARATOR
Intervention: NOAC II (high-dose cytarabine 3 g/m2/12 h on days 1 and 2 + mitoxantrone 10 mg/m2/d on days 2 and 3) without rhGM‐CSF
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: NOAC II with rhGM‐CSF
Number of subjects: 31

Group type: COMPARATOR
Intervention: NOAC II without rhGM‐CSF
Number of subjects: 31
Study: 385094

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Lithium in combination with tryptophan (Optimax)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Tryptophan alone
Number of subjects: 63
Study: 31988481

Group type: EXPERIMENTAL
Intervention: The Daily Mile intervention
Number of subjects: 2256

Group type: EXPERIMENTAL
Intervention: The Daily Mile intervention (specifically in girls)
Number of subjects: 2256

Group type: EXPERIMENTAL
Intervention: The Daily Mile intervention (economic analysis)
Number of subjects: 2256

Group type: COMPARATOR
Intervention: Control group (usual school health and wellbeing activities)
Number of subjects: 2256
Study: 30975953

Group type: EXPERIMENTAL
Intervention: Microwave glazing
Number of subjects: 4

Group type: COMPARATOR
Intervention: Conventional oven glazing
Number of subjects: 4
Study: 28256307

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI 80/4.5 μg (160/9 μg) BID
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI 80/2.25 μg (160/4.5 μg) BID
Number of subjects: 279

Group type: COMPARATOR
Intervention: Budesonide pMDI 80 μg (160 μg) BID
Number of subjects: 279
Study: 25815738

Group type: EXPERIMENTAL
Intervention: Nexfin device
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Impedance cardiography
Number of subjects: 13
Study: 23722456

Group type: EXPERIMENTAL
Intervention: 3 consecutive daily intratympanic injections of 4 mg/ml dexamethasone
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: 3 consecutive weekly injections of 4 mg/ml dexamethasone
Number of subjects: 56
Study: 21193260

Group type: EXPERIMENTAL
Intervention: i-gel™
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: LMA-Supreme™
Number of subjects: 267

Group type: COMPARATOR
Intervention: BVM
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 267

Group type: COMPARATOR
Intervention: LMA-Unique™
Number of subjects: 267

Group type: COMPARATOR
Intervention: LMA-ProSeal™
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: All SADs
Number of subjects: 267
Study: 19273865

Group type: EXPERIMENTAL
Intervention: Immediate blood test
Number of subjects: 498

Group type: COMPARATOR
Intervention: Watchful waiting approach
Number of subjects: 498
Study: 17542503

Group type: EXPERIMENTAL
Intervention: Load-sharing anterior cervical plate (ACP) system
Number of subjects: 50

Group type: COMPARATOR
Intervention: Stress-shielding anterior cervical plate (ACP) system
Number of subjects: 50
Study: 15829494

Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ) 200 mg/m²/day orally for five consecutive days every 4 weeks
Number of subjects: 132

Group type: COMPARATOR
Intervention: Temozolomide (TMZ) + Cisplatin (CDDP) 200 mg/m² daily on days 1-5 and 75 mg/m² of CDDP on day 1
Number of subjects: 132
Study: 11928794

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10234749

Group type: EXPERIMENTAL
Intervention: Peer advisor intervention for unpartnered elders recovering from MI
Number of subjects: 0
Study: 7852219

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 2586199

Group type: EXPERIMENTAL
Intervention: Tamoplex 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nolvadex 10 mg
Number of subjects: 0
Study: 1102399

Group type: EXPERIMENTAL
Intervention: Concentrate of clotting factors
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fresh frozen plasma
Number of subjects: 30
Study: 31314107

Group type: EXPERIMENTAL
Intervention: CPAP therapy (n = 120)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Conservative treatment (n = 127)
Number of subjects: 247
Study: 28189417

Group type: EXPERIMENTAL
Intervention: Nomogram-based FSH starting dose (based on multiple biomarkers)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Age-based FSH starting dose (150 IU if ≤35 years, 225 IU if >35 years)
Number of subjects: 191
Study: 25384017

Group type: EXPERIMENTAL
Intervention: Depression CAREPATH intervention (nurses managing depression at routine home visits with weekly symptom assessment, medication management, care coordination, education, and goal setting)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Depression CAREPATH intervention
Number of subjects: 306

Group type: COMPARATOR
Intervention: Enhanced usual care (control group)
Number of subjects: 306
Study: 23211762

Group type: EXPERIMENTAL
Intervention: Group 1 (20 mg L and 2 mg Z)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Group 2 (10 mg L, 2 mg Z and 10 mg MZ)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Group 3 (3 mg L, 2 mg Z and 17 mg MZ)
Number of subjects: 54
Study: 21560845

Group type: EXPERIMENTAL
Intervention: High dose I-131 treatment (150 microCi/gm, initial mean activity 10.2 mCi)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Low dose I-131 treatment (100 microCi/gm, initial mean activity 8 mCi)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: High dose I-131 treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: Low dose I-131 treatment
Number of subjects: 150
Study: 19705423

Group type: EXPERIMENTAL
Intervention: Voluntary Contraction (VG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Electromyostimulation superimposed on Voluntary Contraction (EVG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study: 16442367

Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin
Number of subjects: 4558

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 4558
Study: 15867743

Group type: EXPERIMENTAL
Intervention: Habit training with an electronic monitoring device
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard habit training (Control)
Number of subjects: 41
Study: 11231429

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg/d)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pravastatin (40 mg/d)
Number of subjects: 200
Study: 9476493

Group type: EXPERIMENTAL
Intervention: Topical bifonazole (Mycospor Solution) alone (group I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical bifonazole (Mycospor Solution) plus 10% urea ointment (Urepearl) (group II)
Number of subjects: 0
Study: 8122478

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 210

Group type: COMPARATOR
Intervention: Pravastatin 20 mg
Number of subjects: 210
Study: 3627208

Group type: EXPERIMENTAL
Intervention: Two doses of oral corticosteroids (methylprednisolone, 32 mg) approximately 12 hours and 2 hours before challenge with contrast material
Number of subjects: 6763
Study: 30067931

Group type: EXPERIMENTAL
Intervention: 4-month regimen of rifampin
Number of subjects: 6859

Group type: COMPARATOR
Intervention: 9-month regimen of isoniazid
Number of subjects: 6859
Study: 26578422

Group type: EXPERIMENTAL
Intervention: Brimonidine/timolol fixed combination (BTFC)
Number of subjects: 95

Group type: COMPARATOR
Intervention: 0.5% timolol
Number of subjects: 95
Study: 26049920

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) combined with cyclosporine A (CsA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclosporine A (CsA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Severe aplastic anemia (SAA) group
Number of subjects: 0
Study: 23701339

Group type: EXPERIMENTAL
Intervention: Propofol with alfentanil (10 μg/kg alfentanil followed by 1 mg/kg propofol, followed by 0.5 mg/kg every 3 minutes as needed)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Propofol only (1 mg/kg propofol, followed by 0.5 mg/kg every 3 minutes as needed)
Number of subjects: 20
Study: 20963671

Group type: EXPERIMENTAL
Intervention: Internet-assisted aftercare group treatment
Number of subjects: 168

Group type: COMPARATOR
Intervention: No additional outpatient psychotherapy (control)
Number of subjects: 168
Study: 17846859

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Ibandronate
Number of subjects: 427

Group type: COMPARATOR
Intervention: HRT (oral, transdermal, intranasal)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Raloxifene
Number of subjects: 427
Study: 16876921

Group type: EXPERIMENTAL
Intervention: Fetal monitoring education programme (1.5 hr duration)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Alternative education programme (non-fetal-monitoring-related video presentation)
Number of subjects: 55
Study: 12801957

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Open label infliximab (10 mg/kg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Open label placebo
Number of subjects: 42
Study: 11199363

Group type: EXPERIMENTAL
Intervention: White wine (300 ml, 8% vol/vol)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ethanol solution (8% vol/vol)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Wet swallow (5 ml)
Number of subjects: 12

Group type: COMPARATOR
Intervention: All beverages (White wine, Ethanol solution, Tap water)
Number of subjects: 12
Study: 8636546

Group type: EXPERIMENTAL
Intervention: Esophageal acid stimulation (0.1 mol/liter hydrochloric acid)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 0.9% saline solution
Number of subjects: 32
Study: 1602194

Group type: EXPERIMENTAL
Intervention: Rees' STA
Number of subjects: 4108

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 4108
Study: 3901244

Group type: EXPERIMENTAL
Intervention: MOCCA chemotherapy regimen (vincristine, methylprednisolone, and 3 alkylating agents)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MOCCA courses bimonthly after 12 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: No further chemotherapy after 12 months
Number of subjects: 50
Study: 28604508

Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy alone
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy with arthroplasty
Number of subjects: 142

Group type: COMPARATOR
Intervention: Anterior cervical discectomy with fusion by plate fixation
Number of subjects: 142
Study: 27148992

Group type: EXPERIMENTAL
Intervention: Occlusal splints (OS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Relining of old denture (RD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 30
Study: 23918212

Group type: EXPERIMENTAL
Intervention: Fenofibrate treatment
Number of subjects: 0
Study: 23451445

Group type: EXPERIMENTAL
Intervention: hylan G-F 20
Number of subjects: 32

Group type: COMPARATOR
Intervention: hyaluronic acid (HA)
Number of subjects: 32
Study: 20484826

Group type: EXPERIMENTAL
Intervention: Single-site Bachmann's bundle pacing (BBp)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Coronary sinus pacing (CSp)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Multisite atrial pacing (MSAp)
Number of subjects: 40
Study: 18283201

Group type: EXPERIMENTAL
Intervention: CONSORT checklist modifications for nonpharmacologic trials
Number of subjects: 33
Study: 16003672

Group type: EXPERIMENTAL
Intervention: Warm-water therapy (40 degrees C)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cold-water therapy (13 degrees C)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Contrast therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 24
Study: 12527252

Group type: EXPERIMENTAL
Intervention: One-legged hopping in patients with ACL reconstruction
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 7
Study: 10655859

Group type: EXPERIMENTAL
Intervention: Opaque foam dressing
Number of subjects: 37

Group type: COMPARATOR
Intervention: Transparent film dressing
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 37